Trial Profile
Phase I clinical trial of TO-206 - Safety trial in patients with Japanese cedar pollinosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Japanese cedar pollen allergy immunotherapy ALK Abello/Torii Pharmaceutical (Primary)
- Indications Seasonal allergic rhinitis
- Focus Adverse reactions
- Sponsors Torii Pharmaceutical
- 07 Nov 2014 New trial record